CG
ANAC

Cutler Group’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Cutler Group’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-40,600
Closed -$946K – 8024
2016
Q1 		$946K Buy
40,600
+19,400
+92% +$1.43M 0.06% 281
2015
Q4 		$53K Buy
+21,200
New +$2.34M ﹤0.01% 2403

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Cutler Group's ANAC Position: Q2 2016 in Review

Cutler Group sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 15,915 shares — an estimated $850K sold.

Cutler Group first reported a position in ANAC in Q4 2015 and held it in 2 quarters. The position peaked at $850K in Q1 2016. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Cutler Group reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Cutler Group sold 15,915 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $850K.
  • Cutler Group first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2015 and held it in 2 quarters.
  • Cutler Group's ANACOR PHARMACEUTICALS INC COM position peaked at $850K in Q1 2016.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Cutler Group's 13F filing for Q2 2016, filed 12 Jul 2016.